Evidence map›Paper›PMID 35896698›Full record

ArticleBone marrow transplantation2022

Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.

Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca, Aiwen Zhang, Dawn Thomas, Valeria Visconte, Jibran Durrani, Ronald M Sobecks, Matt Kalaycio and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Biology of post-transplant relapse: actionable features.Hematology. American Society of Hematology. Education Program · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sanghee HongDepartment of Hematology and Oncology, University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, USA.
Lisa RybickiDepartment of Quantitative Health Science, Lerner Resesarch Institute, Cleveland Clinic, Cleveland, OH, USA.
Carmelo GurnariDepartment of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-6829-5544
Simona PagliucaDepartment of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-4688-2478
Aiwen ZhangAllogen Laboratories, Cleveland Clinic, Cleveland, OH, USA.
Dawn ThomasAllogen Laboratories, Cleveland Clinic, Cleveland, OH, USA.
Valeria VisconteDepartment of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-2993-1509
Jibran DurraniDepartment of Hematology and Oncology, National Institute of Health, Bethesda, MD, USA.
Ronald M SobecksDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Matt KalaycioDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Aaron T GerdsDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-3422-1309
Hetty E CarrawayDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-5241-3614
Sudipto MukherjeeDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-8325-2603
Mikkael A SekeresDivision of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0003-2009-6524
Anjali S AdvaniDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-0015-5902
Navneet S MajhailSarah Cannon, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-7082-891X
Betty K HamiltonDepartment of Hematology and Oncology, National Institute of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-1252-6539
Bhumika J PatelDepartment of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Jaroslaw P MaciejewskiDepartment of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.ORCID http://orcid.org/0000-0002-6837-4346

Funding

Therapeutic Implications of Molecular Defects in Bone Marrow FailureR35HL135795 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P. · 2017 to 2023
$5.7M
NHLBI NIH HHS R35 HL135795
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteMyelodysplastic SyndromesHumansMutation

Identifiers

PMID35896698
PMCPMC10846350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.